Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7

Williams, J.Andrew, Ring, Barbara J., Cantrell, Varon E., Jones, David R., Eckstein, James, Ruterbories, Kenneth, Hamman, Mitchell A., Hall, Stephen D. +1 more·2002·Drug Metabolism and Disposition

DOI 10.1124/dmd.30.8.883

Cited by (472)

Items 301–400 of 472

Structural characterization of the homotropic cooperative binding of azamulin to human cytochrome P450 3A5
Mei‐Hui Hsu, Eric F. Johnson · 2022 · Journal of Biological Chemistry
Identification of Selective CYP3A7 and CYP3A4 Substrates and Inhibitors Using a High-Throughput Screening Platform
Md Kabir, Elias Carvalho Padilha, Pranav Shah, Ruili Huang, Srilatha Sakamuru, Eric R. Gonzalez, Lin Ye, Xin Hu, Mark J. Henderson, Menghang Xia et al. · 2022 · Frontiers in Pharmacology
Pregnancy related hormones increase CYP3A mediated buprenorphine metabolism in human hepatocytes: a comparison to CYP3A substrates nifedipine and midazolam
Muluneh M. Fashe, Taryn A. Miner, John K. Fallon, Amanda P. Schauer, Craig Sykes, Philip C. Smith, Craig R. Lee · 2023 · Frontiers in Pharmacology
Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as a Rat-Specific Diltiazem Deacetylase
Takaya Kurokawa, Tatsuki Fukami, Miki Nakajima · 2015 · Drug Metabolism and Disposition
Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma
Guillermo de Velasco, Kathryn P. Gray, Lana Hamieh, Yüksel Ürün, Hallie A. Carol, André Poisl Fay, Sabina Signoretti, David J. Kwiatkowski, David F. McDermott, Matthew L. Freedman et al. · 2016 · European Urology Focus
How nature tunes isoenzyme activity in the multifunctional catalytic globin dehaloperoxidase from Amphitrite ornata
Leiah M. Carey, Roman Gavenko, Dimitri A. Svistunenko, Reza Arman Ghiladi · 2017 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure
Sarah K. Himes, Yanling Huo, George Kelly Siberry, Paige L. Williams, Mabel L. Rice, Patricia A. Sirois, Toni Frederick, Rohan Hazra, Marilyn Ann Huestis · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Drug Metabolism: Significance and Challenges
Chandra Prakash, Alfin D. N. Vaz · 2008 · Wiley eBooks
Leveraging Physiologically Based Pharmacokinetic Modeling and Experimental Data to Guide Dosing Modification of CYP3A-Mediated Drug-Drug Interactions in the Pediatric Population
Sara N. Salerno, Fernando Olinto Carreño, Andrea N. Edginton, Michael Cohen‐Wolkowiez, Daniel González · 2021 · Drug Metabolism and Disposition
What Is Known about Midazolam? A Bibliometric Approach of the Literature
Maria Cláudia Pinheiro Corôa, Paulo Fernando Santos Mendes, Daiane Claydes Baia-da-Silva, Deiweson Souza‐Monteiro, Maria Karolina Martins Ferreira, Glenda Luciana Costa Braga, Taissa Viana Damasceno, José Messias Perdigão, Rafael Rodrigues Lima · 2022 · Healthcare
Predicting the Effects of Different Triazole Antifungal Agents on the Pharmacokinetics of Tamoxifen
Lu Chen, Liqin Zhu, Mengxue Li, Na Li, Fang Qi, Nan Wang · 2019 · AAPS PharmSciTech
Effect ofcytochrome P450 3A5*3genotype on the stereoselective pharmacokinetics of amlodipine in healthy subjects
Kyoung‐Ah Kim, Pil‐Whan Park, Ji Young Park · 2008 · Chirality
Comparison of the Contributions of Cytochromes P450 3A4 and 3A5 in Drug Oxidation Rates and Substrate Inhibition
Toshiro Niwa, Norie Murayama, Hiroshi Yamazaki · 2010 · Eisei kagaku
Mechanistic Framework to Predict Maternal‐Placental‐Fetal Pharmacokinetics of Nifedipine Employing Physiologically Based Pharmacokinetic Modeling Approach
Marya Antônya Werdan Romão, Leonardo Pinto, Ricardo de Carvalho Cavalli, Geraldo Garcia Duarte, Natália Valadares de Moraes, Khaled Abduljalil, Fernanda de Lima Moreira · 2024 · The Journal of Clinical Pharmacology
Structural Basis for the Diminished Ligand Binding and Catalytic Ability of Human Fetal-Specific CYP3A7
Irina F. Sevrioukova · 2021 · International Journal of Molecular Sciences
Assessment of the Impact of CYP3A Polymorphisms on the Formation of α-Hydroxytamoxifen and N-Desmethyltamoxifen in Human Liver Microsomes
Ganesh M. Mugundu, Larry Sallans, Yingying Guo, Elizabeth Shaughnessy, Pankaj B. Desai · 2011 · Drug Metabolism and Disposition
Relative roles of CYP2C19 and CYP3A4/5 in midazolam 1′-hydroxylation
Chie Emoto, K. Iwasaki · 2007 · Xenobiotica
Differential effects of antiretroviral drug toxicity in male versus female children who are HIV-exposed but uninfected
Julian C. Gilmore, Lena Serghides, Reina Bendayan · 2020 · AIDS
Territrems B and C metabolism in human liver microsomes: Major role of CYP3A4 and CYP3A5
Fu-Chuo Peng, Chiao-Chia Chang, Ching‐Yao Yang, Robert Jeffrey Edwards, Johannes Doehmer · 2005 · Toxicology
Applying whole-genome sequencing in relation to phenotype and outcomes in siblings with cystic fibrosis
Melissa A. Wilk, Andrew T. Braun, Philip M. Farrell, Anita Laxova, Donna M. Brown, James Holt, Camille L. Birch, Nadiya Sosonkina, Brandon M. Wilk, Elizabeth A. Worthey · 2020 · Molecular Case Studies
Cytochrome P450 enzymes in the pediatric population: Connecting knowledge on P450 expression with pediatric pharmacokinetics
Chie Emoto, Trevor N. Johnson · 2022 · Advances in pharmacology
Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives
Antonio Sanz-Solas, Jorge Labrador, Raquel Alcaraz, Beatriz Cuevas, Raquel Vinuesa Campo, María Victoria Cuevas, Miriam Saiz‐Rodríguez · 2023 · Journal of Personalized Medicine
Seizure protection by intrapulmonary delivery of midazolam in mice
Ashish Dhir, Dorota Żółkowska, Michael A. Rogawski · 2013 · Neuropharmacology
Allosteric activation of midazolam CYP3A5 hydroxylase activity by icotinib – Enhancement by ketoconazole
Xiaomei Zhuang, Tianhong Zhang, SiJia Yue, Juan Wang, Huan Luo, Yunxia Zhang, Zheng Li, Jinjing Che, Haiying Yang, Hua Li et al. · 2016 · Biochemical Pharmacology
Metabolism and interactions of pesticides in human and animal in vitro hepatic models
Khaled M. Abass · 2010
Customizing Tacrolimus Dosing in Kidney Transplantation: Focus on Pharmacogenetics
Núria Lloberas, Anna Vidal‐Alabró, Helena Colom · 2024 · Therapeutic Drug Monitoring
IN SILICO DRUG DESIGNING APPROACH FOR BIOTIN PROTEIN LIGASE OF MYCOBACTERIUM TUBERCULOSIS
Pitchai Daisy, Rajamanickam Pon Nivedha, Rajamanickam Helen Bakiya · 2013
Construction and verification of CYP3A5 gene polymorphisms using a Saccharomyces cerevisiae expression system to predict drug metabolism
Yao Lu, Hua Zhong, Qing Tang, Zhijun Huang, Ningning Jing, Julie S Smith, Rujia Miao, Yapei Li, Hong Yuan · 2017 · Molecular Medicine Reports
Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric Model
Lisa R. Ferguson‐Sells, Nieves Vélez de Mendizábal, Baohui Li, David S. Small · 2021 · Clinical Pharmacokinetics
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
NBCS Collaborators, Nichola Johnson, AOCS Group, ABCTB Investigators, kConFab Investigators, Sarah L. Maguire, Anna Morra, Pooja Middha, Katarzyna Tomczyk, Michael Emlyn Jones et al. · 2021 · British Journal of Cancer
Histo-morphological and seminal evaluation of testicular parameters in diabetic rats under antiretroviral therapy: interactions with Hypoxis hemerocallidea.
Ismail Olasile Onanuga, Ayoola Isaac Jegede, Ugochukwu Offor, Oluwatosin Olalekan Ogedengbe, Edwin Cs Naidu, Aniekan Imo Peter, Onyemaechi Okpara Azu · 2018 · Europe PMC (PubMed Central)
Applications of a grid-based CYP3A4 Template system to understand the interacting mechanisms of large-size ligands; part 4 of CYP3A4 Template study
Takahiro Goto, Yasushi Yamazoe, Masahiro Tohkin · 2020 · Drug Metabolism and Pharmacokinetics
Using a pharmacogenetic clinical decision support system to improve psychopharmacotherapy dosing in patients with affective disorders
Михаил Сергеевич Застрожин, Valentin Yurievich Skryabin, Alexander Sorokin, Oleg Zh. Buzik, Бедина Инесса Александровна, Е. А. Гришина, Kristina Ryzhikova, Шипицын Валерий Валериевич, Evgeny Alekseevich Bryun, Dmitry Alekseevich Sychev · 2020 · Drug metabolism and drug interactions
Characterization of fluorescent probe substrates to develop an efficient high-throughput assay for neonatal hepatic CYP3A7 inhibition screening
Hannah M. Work, Sylvie E. Kandel, Jed Noah Lampe · 2021 · Scientific Reports
Using liver models generated from human-induced pluripotent stem cells (iPSCs) for evaluating chemical-induced modifications and disease across liver developmental stages
Celeste K Carberry, S. Ferguson, Adriana S. Beltrán, R. Fry, J. Rager · 2022 · Toxicology in Vitro
Association of cytochromes P450 3A4*22 and 3A5*3 genotypes and polymorphism with response to simvastatin in hypercholesterolemia patients
Elbatool G. Elalem, Musharraf Jelani, Alaa Khedr, Aftab Ahmad, Tareef Y. Alaama, Mohamed Nabeel Alaama, Huda Mohammed Alkreathy, Zoheir Abdullah Damanhouri · 2022 · PLoS ONE
The effect of organic solvents on enzyme kinetic parameters of human CYP3A4 and CYP1A2in vitro
Dennis Rokitta, Kay Pfeiffer, Christina Streich, Henrik Gerwin, Uwe Fuhr · 2013 · Toxicology Mechanisms and Methods
Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate
Madelé van Dyk, Asha J. Kapetas, Ashley Mark Hopkins, A. David Rodrigues, Manoli Vourvahis, Michael Joseph Sorich, Andrew Rowland · 2019 · Frontiers in Pharmacology
In vitro liver models for toxicological research
Ichiro Fukunaga, Takanori Takebe · 2025 · Drug Metabolism and Pharmacokinetics
Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms
Rachda Riffi, Wefa Boughrara, Amina Chentouf, Wassila Ilias, Narimene Malika Taieb Brahim, Amel Alioua Berrebbah, Fatma Belhoucine · 2024 · CNS & Neurological Disorders - Drug Targets
Leveraging Omeprazole PBPK/PD Modeling to Inform Drug–Drug Interactions and Specific Recommendations for Pediatric Labeling
Amira Soliman, Leyanis Rodríguez‐Vera, Ana Alarcia-Lacalle, Leandro Francisco Pippa, Saima Subhani, Viera Lukáčová, Jorge Duconge-Soler, Natália Valadares de Moraes, Valvanera Vozmediano · 2025 · Pharmaceutics
ADME Pharmacogenetics and Its Impact on Drug–Drug Interactions
Reinhold Kerb, Matthias Georg Schwab · 2009 · Springer eBooks
Pharmacokinetic assessment of alprazolam-induced neonatal abstinence syndrome using physiologically based pharmacokinetic model
Kazuhiro Yamamoto, Sachiyo Fukushima, Yui Mishima, Mari Hashimoto, Kei Yamakawa, Kazumichi Fujioka, Kazumoto Iijima, Ikuko Yano · 2019 · Drug Metabolism and Pharmacokinetics
Cytochrome P450 3A5 polymorphism affects the metabolism of sorafenib and its toxicity for hepatocellular carcinoma cells in vitro
Hong-yan Song, Jing-sheng Xia, Yonggang Chen, Ling Chen · 2022 · Human & Experimental Toxicology
Tacrolimus concentrations after renal transplantation in a mother‐neonate dyad: Maternal, neonatal and breast milk measurements
Yumiko Akamine, Nobuhiro Fujiyama, Hideaki Kagaya, Mitsuru Saito, Hiroshi Miura, Yukihiro Terada, Tsutomu Takahashi, Shigeru Satoh, Masatomo Miura · 2021 · Journal of Clinical Pharmacy and Therapeutics
Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders
Stefania Zampatti, Carlo Fabrizio, Michele Ragazzo, Giulia Campoli, Valerio Caputo, Claudia Strafella, Clelia Pellicano, Raffaella Cascella, Gianfranco Spalletta, Laura Petrosini et al. · 2021 · Journal of Personalized Medicine
Cytochrome P450 3A-Dependent Metabolism of a Potent and Selective γ-Aminobutyric AcidAα2/3 Receptor Agonist in Vitro: Involvement of Cytochrome P450 3A5 Displaying Biphasic Kinetics
Bennett Ma, Stacey L. Polsky-Fisher, Stanley Vickers, Donghui Cui, A. David Rodrigues · 2007 · Drug Metabolism and Disposition
Differences of Atomic-Level Interactions between Midazolam and Two CYP Isoforms 3A4 and 3A5
Shuhui Liu, Qing‐Chuan Zheng, Fu‐Quan Bai · 2023 · Molecules
Human cytochrome P450 3A7 binding four copies of its native substrate dehydroepiandrosterone 3-sulfate
Jinghan Liu, Sylvie E. Kandel, Jed Noah Lampe, Emily E. Scott · 2023 · Journal of Biological Chemistry
Prolonged Clonazepam-Induced Withdrawal Symptoms in an NAT2 Ultraslow Acetylator
R COOPERDEHOFF, Sheeba Varghese Gupta, Amarilis Sanchez‐Valle · 2018 · Pharmacogenomics
Changes in Alprazolam Metabolism by CYP3A43 Mutants
Jie Zhao, Sijie Liu, Clemens Alexander Wolf, Gerhard Wolber, Maria Kristina Parr, Matthias Bureik · 2022 · Biomedicines
Pharmacokinetics in pregnancy
Gregory J. Anger, Maged M. Costantine, Micheline Piquette‐Miller · 2011 · Elsevier eBooks
Influence of Cytochrome P450 (CYP)??3A5 Polymorphisms on the Pharmacokinetics of Lansoprazole Enantiomers in CYP2C19 Extensive Metaboliser Renal Transplant Recipients
Masatomo Miura, Kazuyuki Inoue, Shigeru Satoh, Yoshihiko Itoh, Hideaki Kagaya, Hitoshi Tada, Yorihisa Tanaka, Tomonori Habuchi, Toshio Suzuki · 2007 · Clinical Drug Investigation
Cytochrome P450 enzymes— in vitro , in vivo , and in silico studies
Miia Turpeinen · 2006
The effects of lapatinib on CYP3A metabolism of midazolam in patients with advanced cancer
Kevin M. Koch, E. Claire Dees, Shodeinde A. Coker, Nandi J. Reddy, Shelby D. Gainer, Nikita Arya, Andrew Paul Beelen, Lionel D. Lewis · 2017 · Cancer Chemotherapy and Pharmacology
Quantitative evaluation of hepatic and intestinal induction of CYP3A in clinical practice
Haruka Tsutsui, Motohiro Kato, Shino Kuramoto, Nobuo Sekiguchi, Hidetoshi Shindoh, Kazuhisa Ozeki · 2019 · Xenobiotica
A 3D-printed micro-perfused culture device with embedded 3D fibrous scaffold for enhanced biomimicry
Feng Lin Ng, Zhanhong Cen, Yi‐Chin Toh, Lay Poh Tan · 2023 · International Journal of Bioprinting
Variability in Human In Vitro Enzyme Kinetics
Christopher R. Gibson, Ying-Hong Wang, Ninad Ramesh Varkhede, Bennett Ma · 2021 · Methods in molecular biology
Pediatric Dosing Considerations for Medical Cannabis
Jane Alcorn, Stephanie Vuong, Fang Ping Wu, Blair W. Seifert, Andrew William Lyon · 2019 · IntechOpen eBooks
Metabolic detoxification pathways for 5-methoxy-sterigmatocystin in primary tracheal epithelial cells
Odile Cabaret, Olivier Puel, Françoise Botterel, Marcel Delaforge, Stéphane Bretagne · 2013 · Xenobiotica
Lack of Influence by CYP3A4 and CYP3A5 Genotypes on Pain Relief by Hydrocodone in Postoperative Cesarean Section Pain Management
Keivan Hosseinnejad, Tyler Yin, Jeremy Gaskins, M. Elaine Stauble, Yanhong Wu, Paul J. Jannetto, Loralie J. Langman, Saeed A. Jortani · 2018 · The Journal of Applied Laboratory Medicine
Importance of patient selection when determining the significance of the CYP3A5 polymorphism in clinical trials
R. Foti, M B Fisher · 2004 · The Pharmacogenomics Journal
Model-Informed Dose Optimization of Spironolactone in Neonates and Infants
Amira Soliman, Leandro Francisco Pippa, Jana Lass, Stéphanie Leroux, Valvanera Vozmediano, Natália Valadares de Moraes · 2025 · Pharmaceuticals
Deconvoluting Gut Versus Liver Cytochrome P450 3A4 Function: Drug Probes, Biomarkers, and Tissue Biopsy
David Rodrigues · 2026 · The Journal of Clinical Pharmacology
Cytochrome P450 in GtoPdb v.2023.1
Kathryn Elisa Burns, Nuala Ann Helsby · 2023 · IUPHAR/BPS Guide to Pharmacology CITE
Regioselective Versatility of Monooxygenase Reactions Catalyzed by CYP2B6 and CYP3A4: Examples with Single Substrates
Claudio Erratico, Anand K. Deo, Stelvio M. Bandiera · 2015 · Advances in experimental medicine and biology
Reduction of nevirapine-driven HIV mutations by carbamazepine is modulated by CYP3A activity
Dorothea Baranyai, Eva Prosper Muro, Ute Gödtel‐Armbrust, Markus Schirmer, Elton Richard Kisanga, Ulf Diczfalusy, Quirine Fillekes, Rob Schuurman, David Marinus Burger, Leszek Wojnowski · 2014 · Journal of Antimicrobial Chemotherapy
Pharmacogenetic‐Pharmacokinetic Interactions in Drug Marketing Authorization Applications via the European Medicines Agency Between 2014 and 2017
Marc Maliepaard, Timi Toiviainen, Marie L. De Bruin, Didier Meulendijks · 2020 · Clinical Pharmacology & Therapeutics
Comprehensive evaluation of liver microsomal cytochrome P450 3A (CYP3A) inhibition: comparison of cynomolgus monkey and human
Zuzana Haarhoff, Melissa A. Kramer, Tatyana A. Zvyaga, Jun Zhang, Priyadeep Bhutani, Murali Subramanian, A. David Rodrigues · 2016 · Xenobiotica
Effect of Jaeumkanghwatang (JEKHT), a Polyherbal Formula on the Pharmacokinetics Profiles of Tamoxifen in Male SD Rats (1) - Single Oral Combination Treatment of Tamoxifen 50 mg/kg with JEKHT 100 mg/kg within 5 min -
Min Ah Kwak, Soo Jin Park, Sung Hwan Park, Young Joon Lee, Sae‐Kwang Ku · 2016 · 대한한의학회지
In vitro metabolism of helenalin and its inhibitory effect on human cytochrome P450 activity
Michaela Šadibolová, Risto Olavi Juvonen, Seppo O. K. Auriola, Iva Boušová · 2022 · Archives of Toxicology
Cytochrome P450 in GtoPdb v.2021.2
Kathryn Elisa Burns, Nuala Ann Helsby · 2021 · IUPHAR/BPS Guide to Pharmacology CITE
Identification of the human cytochrome P450s responsible for thein vitrometabolism of a leukotriene B4 receptor antagonist, CP-195,543
S. Cyrus Khojasteh-Bakht, Michelle I. Rossulek, Hassan G. Fouda, Chandra Prakash · 2003 · Xenobiotica
CYP3A5 is Unlikely to Mediate Anticancer Drug Resistance in Hepatocellular Carcinoma
Volker Martin Lauschke, Åsa Nordling, Yitian Zhou, Sara Fontalva, Isabel Barragán, Magnus Ingelman‐Sundberg · 2019 · Pharmacogenomics
Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir
Jun Matsumoto, Su Nwe San, Masachika Fujiyoshi, Ayano Kawauchi, Natsumi Chiba, Ran Tagai, Ryoko Sanbe, Shiho Yanaka, Hiroaki Sakaue, Yoshinori Kato et al. · 2019 · Journal of Human Genetics
Hepatic Stem Cells and Liver Development
Nalu Navarro–Álvarez, Alejandro Soto–Gutiérrez, Naoya Kobayashi · 2009 · Humana Press eBooks
Clinical implications of neuropharmacogenetics
Jean‐Christophe Corvol, David Devos, Jean‐Sébastien Hulot, Lucette Lacomblez · 2015 · Revue Neurologique
Xenobiotic metabolism and zebrafish (danio rerio) larvae
Huw Simon Jones · 2010 · University of Birmingham Institutional Research Archive (University of Birmingham)
Metabolisme av midazolam via CYP3A4 og CYP3A5 in vitro : utvikling av LC/MS-metode for analyse av hydroksylerte metabolitter
Lillian Wåge Postvoll · 2006 · NORA - Norwegian Open Research Archives
Multicenter Population Pharmacokinetics of Fentanyl in Neonatal Surgical Patients Using Dried Blood Spot Specimen Collection Demonstrates Maturation of Elimination Clearance
Rachael Rzasa Lynn, Thomas K. Henthorn, Jeannie Zuk, Gregory B. Hammer, David R. Drover, Richard J. Levy, Lynne Gerson Maxwell, Senthilkumar Sadhasivam, Santhanam Suresh, Jeffrey L. Galinkin · 2024 · Anesthesia & Analgesia
Assessing Pharmacogenomic loci Associated with the Pharmacokinetics of Vamorolone in Boys with Duchenne Muscular Dystrophy
Xiaonan Li, Daniele Sabbatini, Elena Pegoraro, Luca Bello, Paula R. Clemens, Michela Guglieri, John N. van den Anker, Jesse M. Damsker, John McCall, Utkarsh J. Dang et al. · 2024 · The Journal of Clinical Pharmacology
Physiologically based pharmacokinetic modelling to predict artemether and lumefantrine exposure in neonates weighing less than 5 kg treated with artemether–lumefantrine to supplement the clinical data from the CALINA study
Helen Gu, Nada Abla, Vinay Kumar Venishetty, Birgit Schoeberl, Julia Zack, Heidi J. Einolf · 2025 · Tropical Medicine and Health
Variability in Human In Vitro Enzyme Kinetics
Ying-Hong Wang, Christopher R. Gibson · 2014 · Methods in molecular biology
The Role of Direct Acting Anti-Virals in Chronic Hepatitis C Treatment-2016 Update
Andrew Ofosu, Raja Koteswar Dhanekula · 2016 · Journal of Antivirals & Antiretrovirals
Treatment-related transient splenial lesion of the Corpus Callosum in patients with neuropsychiatric disorders: a literature overview with a case report
Giovanna Cirnigliaro, Ilaria Di Bernardo, Valentina Caricasole, Eleonora Piccoli, Barbara Scaramelli, Simone Pomati, Chiara Villa, Leonardo Pantoni, Bernardo Maria Dell’Osso · 2020 · Expert Opinion on Drug Safety
СИНЕРГІЯ ВПЛИВУ ПОЛІМОРФНИХ ВАРІАНТІВ ГЕНІВ СИСТЕМИ ПЕРШОЇ ТА ДРУГОЇ ФАЗИ ДЕТОКСИКАЦІЇ КСЕНОБІОТИКІВ І ПСИХО-ЕМОЦІЙНОГО СТРЕСУ НА РЕПРОДУКТИВНЕ ЗДОРОВ’Я ЧОЛОВІКА: ОГЛЯД ЛІТЕРАТУРИ ТА КЛІНІЧНИЙ ВИПАДОК
Анастасія Миколаївна Маковецька, Людмила Олександрівна Турова, Марина Володимирівна Савельєва · 2023 · Men’s Health Gender and Psychosomatic Medicine
Effect of the Single Oral Combination Treatment of Tamoxifen with Gamisoyo-san on the Pharmacokinetics Profiles of Tamoxifen
Joo-Ik Kim, Sae‐Kwang Ku, Lee surname · 2020 · 동의생리병리학회지
In Vitro–In SilicoTools to Predict Pharmacokinetics of Poorly Soluble Drug Compounds
Christian Wagner, Jennifer Dressman · 2014 · Wiley eBooks
The Role of ID3 and PCB153 in the Hyperproliferation and Dysregulation of Lung Endothelial Cells
Mayur Doke · 2018
Design and performance of a long-read sequencing panel for pharmacogenomics
Maaike van der Lee, Loes Busscher, Roberta Menafra, Qinglian Zhai, Redmar R. van den Berg, Sarah B. Kingan, Nina Gonzaludo, Ting Hon, Ting Han, Leonardo Arbiza et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Pharmacokinetic herb-drug interaction study of selected traditional medicines used as complementary and alternative medicine (CAM) for HIV/AIDS
Charles Awortwe · 2015 · SUNScholar (Stellenbosch University)
Efficacy and Safety of Statins in Ethnic Differences: A Lesson for Application in Indigenous Australian Patient Care
Lemlem Gebremedhin Gebremichael, Vijayaprakash Suppiah, Michael David Wiese, Lorraine Mackenzie, Craig Phillips, Desmond B Williams, Michael Stephen Roberts · 2021 · Pharmacogenomics
Simultaneous Determination of Cortisol and 6β-Hydroxycortisol in Human Plasma by Liquid Chromatography–Tandem Mass Spectrometry
Luning Sun, Ye Shen, Yu-Qing Yang, Xiang‐Long Chen, Feng‐Ru Huang, Dun‐Jian Wang, Ye Zhang, Yongqing Wang, Yongqing Wang · 2022 · Journal of Chromatographic Science
The rational use of PBPK to assess the changing DDI liability in pediatrics: Model qualification and the move towards best practice
Trevor N. Johnson, Jean Dinh, Roz Southall, Amin Rostami‐Hodjegan · 2025 · Drug Metabolism and Pharmacokinetics
Effect of 2.5 hr-interval single oral combination treatment of Gamisoyo-san with Tamoxifen on the pharmacokinetics profiles of Tamoxifen in rats
Joo-Ik Kim, Sae‐Kwang Ku, Young Joon Lee · 2020 · 대한한의학회지
Theoretical Study on the Metabolic Mechanism of Heptachlor in Human Cytochrome P450 Enzymes
Xuerui Zhao, Hao Zhang, Xiaoli Shen, Qing‐Chuan Zheng, Song Wang · 2025 · International Journal of Molecular Sciences
Neonatal PBPK model of midazolam and its metabolites for perinatal asphyxia and therapeutic hypothermia
Karen Leys, Agustos C. Ozbey, Miao‐Chan Huang, Julia Macente, Marina‐Stefania Stroe, Timo Robert de Haan, Floris Groenendaal, Évelyne Jacqz-Aigrain, Saskia N. de Wildt, Karel Allegaert et al. · 2026 · British Journal of Clinical Pharmacology
Design, Synthesis, and Biological Evaluation of Novel Quinazoline–Thiazole Hybrids As Potential Anticancer Agents
Sobhi M. Gomha, Sami A. Al‐Hussain, Basant Farag, Nahlah A. Alhadhrami, Magdi E. A. Zaki, AbdElAziz A. Nayl, Abdelwahed Rashad Sayed, Ahmed A. M. El‐Reedy · 2026 · Journal of Biochemical and Molecular Toxicology
The role of genetic factors in determining the clinical efficacy of clopidogrel.
Reni Tzveova, Atanaska Velichkova Mitkova, I. Paskaleva, Radka Petrova Kaneva, Vanio Mitev · 2013 · S'rdechno-s'dovi Zabolyavaniya / Medical Review - Cardiovascular Diseases
Pharmacokinetic Interactions: Core Concepts
Erica D. Wittwer, Wayne T. Nicholson · 2015 · Springer eBooks